AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 229 filers reported holding AMICUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,608,000 | -6.4% | 587,277 | -5.5% | 0.18% | -7.2% |
| Q2 2021 | $5,993,000 | -2.4% | 621,659 | 0.0% | 0.20% | -7.6% |
| Q1 2021 | $6,142,000 | -34.4% | 621,659 | +53.3% | 0.21% | -35.9% |
| Q4 2020 | $9,366,000 | +63.5% | 405,626 | 0.0% | 0.33% | +53.0% |
| Q3 2020 | $5,727,000 | +12.7% | 405,626 | +20.4% | 0.22% | +11.4% |
| Q2 2020 | $5,082,000 | +49.1% | 336,984 | -8.7% | 0.19% | +25.3% |
| Q1 2020 | $3,409,000 | -5.1% | 368,960 | 0.0% | 0.15% | +13.2% |
| Q4 2019 | $3,594,000 | +42.4% | 368,960 | +17.3% | 0.14% | +23.6% |
| Q3 2019 | $2,523,000 | -35.7% | 314,597 | 0.0% | 0.11% | -31.2% |
| Q2 2019 | $3,926,000 | -8.2% | 314,597 | 0.0% | 0.16% | -8.0% |
| Q1 2019 | $4,279,000 | -49.0% | 314,597 | -64.1% | 0.17% | -51.5% |
| Q4 2018 | $8,385,000 | -20.8% | 875,304 | 0.0% | 0.36% | -6.5% |
| Q3 2018 | $10,582,000 | -22.6% | 875,304 | 0.0% | 0.38% | -26.0% |
| Q2 2018 | $13,672,000 | +3.9% | 875,304 | 0.0% | 0.52% | +1.4% |
| Q1 2018 | $13,165,000 | +51.2% | 875,304 | +44.7% | 0.51% | +52.4% |
| Q4 2017 | $8,705,000 | +109.6% | 604,920 | +119.6% | 0.34% | +127.0% |
| Q3 2017 | $4,154,000 | +156.6% | 275,494 | +71.4% | 0.15% | +146.7% |
| Q2 2017 | $1,619,000 | -45.8% | 160,730 | -61.6% | 0.06% | -48.3% |
| Q1 2017 | $2,986,000 | +43.5% | 418,730 | 0.0% | 0.12% | +30.3% |
| Q4 2016 | $2,081,000 | +9.0% | 418,730 | +62.3% | 0.09% | +21.9% |
| Q3 2016 | $1,909,000 | +35.5% | 258,000 | 0.0% | 0.07% | +25.9% |
| Q2 2016 | $1,409,000 | -35.4% | 258,000 | 0.0% | 0.06% | -37.6% |
| Q1 2016 | $2,180,000 | – | 258,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |